Logo image of ALAGR.PA

AGROGENERATION (ALAGR.PA) Stock Fundamental Analysis

Europe - EPA:ALAGR - FR0010641449 - Common Stock

0.049 EUR
0 (0%)
Last: 9/29/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALAGR gets a fundamental rating of 2 out of 10. We evaluated ALAGR against 58 industry peers in the Food Products industry. ALAGR has a bad profitability rating. Also its financial health evaluation is rather negative. ALAGR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALAGR had negative earnings in the past year.
ALAGR had a positive operating cash flow in the past year.
In multiple years ALAGR reported negative net income over the last 5 years.
In the past 5 years ALAGR always reported a positive cash flow from operatings.
ALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.78%, ALAGR is doing worse than 86.21% of the companies in the same industry.
ALAGR has a Return On Equity of -13.83%. This is amonst the worse of the industry: ALAGR underperforms 82.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.55%, ALAGR is doing worse than 72.41% of the companies in the same industry.
Industry RankSector Rank
ROA -6.78%
ROE -13.83%
ROIC 2.55%
ROA(3y)-39.45%
ROA(5y)-19.55%
ROE(3y)-99.8%
ROE(5y)-52.84%
ROIC(3y)N/A
ROIC(5y)N/A
ALAGR.PA Yearly ROA, ROE, ROICALAGR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

ALAGR has a Operating Margin of 2.84%. This is in the lower half of the industry: ALAGR underperforms 70.69% of its industry peers.
In the last couple of years the Operating Margin of ALAGR has declined.
With a Gross Margin value of 25.38%, ALAGR is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALAGR has grown nicely.
Industry RankSector Rank
OM 2.84%
PM (TTM) N/A
GM 25.38%
OM growth 3Y-46.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.39%
GM growth 5Y217.67%
ALAGR.PA Yearly Profit, Operating, Gross MarginsALAGR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAGR is destroying value.
The number of shares outstanding for ALAGR remains at a similar level compared to 1 year ago.
ALAGR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALAGR has been reduced compared to a year ago.
ALAGR.PA Yearly Shares OutstandingALAGR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ALAGR.PA Yearly Total Debt VS Total AssetsALAGR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -10.27, we must say that ALAGR is in the distress zone and has some risk of bankruptcy.
ALAGR has a Altman-Z score of -10.27. This is amonst the worse of the industry: ALAGR underperforms 91.38% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that ALAGR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.67, ALAGR perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z -10.27
ROIC/WACC0.64
WACC3.96%
ALAGR.PA Yearly LT Debt VS Equity VS FCFALAGR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ALAGR has a Current Ratio of 1.36. This is a normal value and indicates that ALAGR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.36, ALAGR is in line with its industry, outperforming 51.72% of the companies in the same industry.
A Quick Ratio of 0.16 indicates that ALAGR may have some problems paying its short term obligations.
ALAGR has a worse Quick ratio (0.16) than 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.16
ALAGR.PA Yearly Current Assets VS Current LiabilitesALAGR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

ALAGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.58%, which is quite impressive.
Looking at the last year, ALAGR shows a very strong growth in Revenue. The Revenue has grown by 33.94%.
The Revenue has been decreasing by -5.83% on average over the past years.
EPS 1Y (TTM)82.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.08%
Revenue 1Y (TTM)33.94%
Revenue growth 3Y-19.79%
Revenue growth 5Y-5.83%
Sales Q2Q%82.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALAGR.PA Yearly Revenue VS EstimatesALAGR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALAGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAGR.PA Price Earnings VS Forward Price EarningsALAGR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALAGR indicates a rather cheap valuation: ALAGR is cheaper than 86.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.83
ALAGR.PA Per share dataALAGR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGROGENERATION

EPA:ALAGR (9/29/2025, 7:00:00 PM)

0.049

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.86M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF 10.23
P/B 0.98
P/tB 0.99
EV/EBITDA 3.83
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY9.77%
SpS0.1
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.78%
ROE -13.83%
ROCE 3.47%
ROIC 2.55%
ROICexc 2.55%
ROICexgc 2.56%
OM 2.84%
PM (TTM) N/A
GM 25.38%
FCFM N/A
ROA(3y)-39.45%
ROA(5y)-19.55%
ROE(3y)-99.8%
ROE(5y)-52.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-37.02%
ROICexcg growth 5YN/A
ROICexc growth 3Y-37.05%
ROICexc growth 5YN/A
OM growth 3Y-46.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.39%
GM growth 5Y217.67%
F-Score6
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 23.11%
Cap/Sales 4.79%
Interest Coverage 19.52
Cash Conversion 19.85%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 0.16
Altman-Z -10.27
F-Score6
WACC3.96%
ROIC/WACC0.64
Cap/Depr(3y)18.27%
Cap/Depr(5y)22.66%
Cap/Sales(3y)4.2%
Cap/Sales(5y)4.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.94%
Revenue growth 3Y-19.79%
Revenue growth 5Y-5.83%
Sales Q2Q%82.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.39%
EBIT growth 3Y-56.92%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.98%
OCF growth 3Y-62.67%
OCF growth 5YN/A